ProQR Therapeutics N.V.

SecurityPRQR / ProQR Therapeutics N.V.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership24,868 shares
Latest Disclosed Value $ 40,286
Simplex Trading, Llc ownership in PRQR / ProQR Therapeutics N.V.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 24,868 shares of ProQR Therapeutics N.V. (US:PRQR) valued at $40,286 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 44,269 shares of ProQR Therapeutics N.V.. This represents a change in shares of -43.83% during the quarter. The current value of the position is $36,556 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (PRQR) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PRQR / ProQR Therapeutics N.V. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F PROQR THRAPEUTICS N V COM N71542109 24,868 -19,401 -43.83 40 -55.06 0.0000
2026-02-11 2025-12-31 13F PROQR THRAPEUTICS N V COM N71542109 44,269 44,269 89 0.0001
2025-11-12 2025-09-30 13F PROQR THRAPEUTICS N V COM N71542109 0 -856 -100.00 0 0.0000
2025-08-05 2025-06-30 13F PROQR THRAPEUTICS N V COM N71542109 856 -3,252 -79.16 0 0.0000
2025-05-12 2025-03-31 13F PROQR THRAPEUTICS N V COM N71542109 4,108 -5,801 -58.54 0 0.0000
2025-02-11 2024-12-31 13F PROQR THRAPEUTICS N V COM N71542109 9,909 9,909 0 0.0000
2024-11-08 2024-09-30 13F PROQR THRAPEUTICS N V COM N71542109 0 -6,628 -100.00 0 0.0000
2024-07-25 2024-06-30 13F PROQR THRAPEUTICS N V COM N71542109 6,628 -6,922 -51.08 0 0.0000
2024-04-25 2024-03-31 13F PROQR THRAPEUTICS N V COM N71542109 13,550 11,756 655.30 0 0.0000
2024-02-02 2023-12-31 13F PROQR THRAPEUTICS N V COM N71542109 1,794 -12,895 -87.79 0 0.0000
2023-11-01 2023-09-30 13F PROQR THRAPEUTICS N V COM N71542109 14,689 8,159 124.95 0 0.0000
2023-08-04 2023-06-30 13F PROQR THRAPEUTICS N V COM N71542109 6,530 -79,622 -92.42 0 0.0000
2023-04-27 2023-03-31 13F PROQR THRAPEUTICS N V COM N71542109 86,152 50,787 143.61 0 0.0002
2023-02-02 2022-12-31 13F PROQR THRAPEUTICS N V COM N71542109 35,365 32,922 1,347.61 0 -100.00 0.0001
2022-11-04 2022-09-30 13F PROQR THRAPEUTICS N V COM N71542109 2,443 2,400 5,581.40 1 0.0000
2022-08-03 2022-06-30 13F PROQR THRAPEUTICS N V COM N71542109 43 43 0 0.0000
2022-05-02 2022-03-31 13F PROQR THRAPEUTICS N V COM N71542109 0 -16,291 -100.00 0 -100.00
2022-02-23 2021-12-31 13F/A-1 PROQR THRAPEUTICS N V COM N71542109 16,291 16,291 130 0.0001
2021-08-12 2021-06-30 13F PROQR THRAPEUTICS N V COM N71542109 0 -122,183 -100.00 0 -100.00
2021-04-26 2021-03-31 13F PROQR THRAPEUTICS N V COM N71542109 122,183 119,196 3,990.49 807 6,625.00 0.0015
2021-02-02 2020-12-31 13F PROQR THRAPEUTICS N V COM N71542109 2,987 2,971 18,568.75 12 -98.51 0.0000
2020-10-14 2020-09-30 13F PROQR THRAPEUTICS N V COM N71542109 16 -1,837 -99.14 0 -100.00
2020-07-13 2020-06-30 13F PROQR THRAPEUTICS N V COM N71542109 1,853 -22,631 -92.43 11 -91.79 0.0000
2020-04-29 2020-03-31 13F PROQR THRAPEUTICS N V COM N71542109 24,484 24,484 1,221.32 134 1,118.18 0.0002
2020-02-05 2019-12-31 13F PROQR THRAPEUTICS N V COM N71542109 0 -100 -100.00 0 -100.00 0.0000
2019-10-15 2019-09-30 13F PROQR THRAPEUTICS N V COM N71542109 100 100 0 0.0000
2019-07-26 2019-06-30 13F PROQR THRAPEUTICS N V COM N71542109 0 -52 -100.00 0 0.0000
2019-04-18 2019-03-31 13F PROQR THRAPEUTICS N V COM N71542109 52 52 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F PROQR THRAPEUTICS N V CALL Call 0 -100.00 0 n/a n/a n/a
2025-11-12 2025-09-30 13F PROQR THRAPEUTICS N V CALL Call 100 -99.79 0 n/a n/a n/a
2025-08-05 2025-06-30 13F PROQR THRAPEUTICS N V CALL Call 47,300 350.48 0 n/a n/a n/a
2025-05-12 2025-03-31 13F PROQR THRAPEUTICS N V CALL Call 10,500 -3.67 0 n/a n/a n/a
2025-02-11 2024-12-31 13F PROQR THRAPEUTICS N V CALL Call 10,900 -86.71 0 n/a n/a n/a
2024-11-08 2024-09-30 13F PROQR THRAPEUTICS N V CALL Call 82,000 9,011.11 0 n/a n/a n/a
2024-07-25 2024-06-30 13F PROQR THRAPEUTICS N V CALL Call 900 -83.02 0 n/a n/a n/a
2024-04-25 2024-03-31 13F PROQR THRAPEUTICS N V CALL Call 5,300 5,200.00 0 n/a n/a n/a
2024-02-02 2023-12-31 13F PROQR THRAPEUTICS N V CALL Call 100 -90.00 0 n/a n/a n/a
2023-11-01 2023-09-30 13F PROQR THRAPEUTICS N V CALL Call 1,000 -86.11 0 n/a n/a n/a
2023-08-04 2023-06-30 13F PROQR THRAPEUTICS N V CALL Call 7,200 -61.29 0 n/a n/a n/a
2023-04-27 2023-03-31 13F PROQR THRAPEUTICS N V CALL Call 18,600 53.72 0 n/a n/a n/a
2023-02-02 2022-12-31 13F PROQR THRAPEUTICS N V CALL Call 12,100 -34.59 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F PROQR THRAPEUTICS N V CALL Call 18,500 -39.54 13 -43.48 n/a n/a n/a
2022-08-03 2022-06-30 13F PROQR THRAPEUTICS N V CALL Call 30,600 -79.28 23 -82.71 n/a n/a n/a
2022-05-02 2022-03-31 13F PROQR THRAPEUTICS N V CALL Call 147,700 457.36 133 -37.26 n/a n/a n/a
2022-02-23 2021-12-31 13F/A PROQR THRAPEUTICS N V CALL Call 26,500 24.41 212 50.35 n/a n/a n/a
2022-02-04 2021-12-31 13F PROQR THRAPEUTICS N V CALL Call 21,300 141 n/a n/a n/a
2021-10-28 2021-09-30 13F PROQR THRAPEUTICS N V CALL Call 21,300 0.00 141 -1.40 n/a n/a n/a
2021-08-12 2021-06-30 13F PROQR THRAPEUTICS N V CALL Call 21,300 3,630.30 143 -62.07 n/a n/a n/a
2021-04-26 2021-03-31 13F PROQR THRAPEUTICS N V CALL Call 571 -97.32 377 163.64 n/a n/a n/a
2020-10-14 2020-09-30 13F PROQR THRAPEUTICS N V CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-13 2020-06-30 13F PROQR THRAPEUTICS N V CALL Call 1 -50.00 0 -100.00 n/a n/a n/a
2020-04-29 2020-03-31 13F PROQR THRAPEUTICS N V CALL Call 2 100.00 1 n/a n/a n/a
2020-02-05 2019-12-31 13F PROQR THRAPEUTICS N V CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-10-15 2019-09-30 13F PROQR THRAPEUTICS N V CALL Call 1 0 n/a n/a n/a
2019-04-18 2019-03-31 13F PROQR THRAPEUTICS N V CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-01-16 2018-12-31 13F PROQR THRAPEUTICS N V CALL Call 1 1 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-05 2025-06-30 13F PROQR THRAPEUTICS N V PUT Put 0 -100.00 0 n/a n/a n/a
2025-05-12 2025-03-31 13F PROQR THRAPEUTICS N V PUT Put 6,900 0.00 0 n/a n/a n/a
2025-02-11 2024-12-31 13F PROQR THRAPEUTICS N V PUT Put 6,900 263.16 0 n/a n/a n/a
2024-11-08 2024-09-30 13F PROQR THRAPEUTICS N V PUT Put 1,900 0.00 0 n/a n/a n/a
2024-07-25 2024-06-30 13F PROQR THRAPEUTICS N V PUT Put 1,900 18.75 0 n/a n/a n/a
2024-04-25 2024-03-31 13F PROQR THRAPEUTICS N V PUT Put 1,600 60.00 0 n/a n/a n/a
2024-02-02 2023-12-31 13F PROQR THRAPEUTICS N V PUT Put 1,000 -86.67 0 n/a n/a n/a
2023-11-01 2023-09-30 13F PROQR THRAPEUTICS N V PUT Put 7,500 -38.52 0 n/a n/a n/a
2023-08-04 2023-06-30 13F PROQR THRAPEUTICS N V PUT Put 12,200 -91.04 0 n/a n/a n/a
2023-04-27 2023-03-31 13F PROQR THRAPEUTICS N V PUT Put 136,100 343.32 0 n/a n/a n/a
2023-02-02 2022-12-31 13F PROQR THRAPEUTICS N V PUT Put 30,700 2,092.86 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F PROQR THRAPEUTICS N V PUT Put 1,400 1 n/a n/a n/a
2022-08-03 2022-06-30 13F PROQR THRAPEUTICS N V PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-02 2022-03-31 13F PROQR THRAPEUTICS N V PUT Put 2,800 -51.72 2 -95.65 n/a n/a n/a
2022-02-23 2021-12-31 13F/A PROQR THRAPEUTICS N V PUT Put 5,800 -85.57 46 -82.71 n/a n/a n/a
2022-02-04 2021-12-31 13F PROQR THRAPEUTICS N V PUT Put 40,200 266 n/a n/a n/a
2021-10-28 2021-09-30 13F PROQR THRAPEUTICS N V PUT Put 40,200 0.00 266 -1.48 n/a n/a n/a
2021-08-12 2021-06-30 13F PROQR THRAPEUTICS N V PUT Put 40,200 4,406.73 270 -54.16 n/a n/a n/a
2021-04-26 2021-03-31 13F PROQR THRAPEUTICS N V PUT Put 892 -97.78 589 118.15 n/a n/a n/a
2021-02-02 2020-12-31 13F PROQR THRAPEUTICS N V PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-10-14 2020-09-30 13F PROQR THRAPEUTICS N V PUT Put 4 1 n/a n/a n/a
2020-07-13 2020-06-30 13F PROQR THRAPEUTICS N V PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-04-29 2020-03-31 13F PROQR THRAPEUTICS N V PUT Put 16 8 n/a n/a n/a
2020-02-05 2019-12-31 13F PROQR THRAPEUTICS N V PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-10-15 2019-09-30 13F PROQR THRAPEUTICS N V PUT Put 1 0 n/a n/a n/a
2019-07-26 2019-06-30 13F PROQR THRAPEUTICS N V PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-04-18 2019-03-31 13F PROQR THRAPEUTICS N V PUT Put 20 27 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.